Cancer Therapy News and Research

RSS

Cancer prehabilitation has potential to reduce problems, improve physical and mental health outcomes

For patients with cancer, "prehabilitation"— interventions given between the time of diagnosis and the start of treatment—has the potential to reduce complications from treatments and improve physical and mental health outcomes, according to a report in the August American Journal of Physical Medicine & Rehabilitation.

19 Jul 2013

UK Markey Cancer Center receives National Cancer Institute designation

The University of Kentucky Markey Cancer Center was joined by national, state and local leaders last Friday to celebrate its designation as a National Cancer Institute cancer center.

19 Jul 2013

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.

From Quest Diagnostics 18 Jul 2013

Breast cancer pilot study: Patients benefit from treatments guided by molecular profiling

The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute, Translational Drug Development and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling.

18 Jul 2013

Novel way to fine-tune activity of cells' protein-disposing machinery with cancer-fighting effects

Molecular biologists in the School of Medicine at The University of Texas Health Science Center San Antonio have found a novel way to fine-tune the activity of cells' protein-disposing machinery, with potentially cancer-fighting effects.

18 Jul 2013

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.

18 Jul 2013

Women who survive cancer have severe menopausal hot flashes

Women who survive cancer have more frequent, severe, and troubling hot flashes than other women with menopausal symptoms, according to a study published online today in Menopause, the journal of The North American Menopause Society (NAMS).

17 Jul 2013

TAp73 protein frequently overexpressed in wide range of human tumors

They say you can pick your friends, but not your family. The same may hold true for related proteins. The protein TAp73 is a relative of the well-known, tumor-suppressor protein p53. It shares extensive common gene sequences with p53 and, as suggested by some previous studies, it may function similar to p53 to prevent tumor formation.

17 Jul 2013

State highlights: Minn. health plans stockpile nearly $2B in cash; Calif. law to offer health care to immigrants in U.S. illegally

After four straight years of profitable growth, Minnesota's health plans have stockpiled a substantial surplus of cash reserves. The health insurance companies, which get nearly three-quarters of their business from state and federal programs, now have more than $1.9 billion in reserves -- $1.3 billion more than required by state law, according to a review by Twin Cities health care analyst Allan Baumgarten (Crosby, 7/15).

17 Jul 2013

One step closer to understanding how to control cancer cells without harming healthy ones

The nasty side effects of radiation and chemotherapy are well known: fatigue, hair loss and nausea, to name a few. Cancer treatment can seem as harsh as the disease because it can't differentiate healthy cells from cancerous cells, killing both.

17 Jul 2013

White blood cells and the spread of cancer: an interview with Drs. Lorenzo Ferri and Jonathan Cools-Lartigue, McGill University

As surgeons who take care of cancer patients, we have observed a troubling association between patients who suffer from infections after surgery and the rapid spread of their cancer. We have reported this in lung cancer patients, and others have made these observations in a variety of different cancers. However, the mechanisms responsible for this association are still poorly understood.

16 Jul 2013

CUMC researchers develop new approach to tailor cancer therapy for individual patient

Columbia University Medical Center (CUMC) researchers are developing a new approach to cancer clinical trials, in which therapies are designed and tested one patient at a time.

16 Jul 2013

York physicists study how heating effect of experimental cancer treatment works

Physicists from the University of York have carried out new research into how the heating effect of an experimental cancer treatment works.

15 Jul 2013

Childhood cancer survivors can still get pregnant despite increased risk of infertility

Although women who survived childhood cancer face an increased risk of infertility, nearly two-thirds of those who tried unsuccessfully to become pregnant for at least a year eventually conceived, according to clinical researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Brigham and Women's Hospital. This is comparable to the rate of eventual pregnancy among all clinically infertile women.

15 Jul 2013

Scientists discover novel method to kill cancer cells

A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way of killing cancer cells. The research, recently published in the journal Cell, has found a new potential treatment for cancer, which leaves the body's healthy cells undamaged, unlike traditional therapies such as radiotherapy

15 Jul 2013

New theory challenges orthodox view that cancer develops in each host by mutational accidents

A new way to look at cancer -- by tracing its deep evolutionary roots to the dawn of multicellularity more than a billion years ago -- has been proposed by Paul Davies of Arizona State University's Beyond Center for Fundamental Concepts in Science in collaboration with Charles Lineweaver of the Australian National University.

15 Jul 2013

Cancer Therapy News and Research

Cancer prehabilitation has potential to reduce problems, improve physical and mental health outcomes

UK Markey Cancer Center receives National Cancer Institute designation

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Breast cancer pilot study: Patients benefit from treatments guided by molecular profiling

Novel way to fine-tune activity of cells' protein-disposing machinery with cancer-fighting effects

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Women who survive cancer have severe menopausal hot flashes

TAp73 protein frequently overexpressed in wide range of human tumors

State highlights: Minn. health plans stockpile nearly $2B in cash; Calif. law to offer health care to immigrants in U.S. illegally

One step closer to understanding how to control cancer cells without harming healthy ones

White blood cells and the spread of cancer: an interview with Drs. Lorenzo Ferri and Jonathan Cools-Lartigue, McGill University

CUMC researchers develop new approach to tailor cancer therapy for individual patient

York physicists study how heating effect of experimental cancer treatment works

Childhood cancer survivors can still get pregnant despite increased risk of infertility

Scientists discover novel method to kill cancer cells

New theory challenges orthodox view that cancer develops in each host by mutational accidents

Researchers find new potential treatment for cancer

Global recruitment drive to bring best cancer experts to Manchester now underway

New concept could improve cancer drug delivery

USMD Holdings extends patient-centric medical care to Alaska

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News